NEW YORK — PixCell Medical said on Monday that it has signed a distribution agreement for its HemoScreen Hematology Analyzer in Sweden with Triolab.
HemoScreen is a portable, point-of-care complete blood count analyzer that uses disposable cartridges that include all necessary reagents and provides results from a single drop of blood from a fingerstick.
Under the terms of the deal, Triolab will be the exclusive distributor of HemoScreen in Sweden.
Additional terms were not disclosed.
Although HemoScreen has been CE marked for a number of years, Yokneam, Israel-based PixCell has been focused on building relationships in different markets before undertaking full-scale commercial launches. The company has said it intends to commercialize the analyzer in the US, where it received clearance in 2018, this year.